Attachment L-7 Teaming Subcontractor Consent Ltr.docx

DOCX document 17 KB Posted

Attached to
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) Federal contract opportunity
Solicitation number
HT940220R0002
Issued by
Defense Health Agency

About this file

This draft request for proposal concerns pharmacy services for the TRICARE program. The Defense Health Agency intends to award a new stand-alone contract to provide pharmacy benefits to TRICARE beneficiaries. The potential single-award contract would have an 18-month transition period and seven 1-year option periods for service delivery, with an additional 6-month extension permitted. The draft RFP includes sections on contract line item structure, specialty pharmacy services, retail pharmacy networks, care coordination, patient safety notifications, and quality control. Interested vendors are invited to provide feedback on these sections by January 17, 2020. The agency anticipates releasing a formal RFP in mid-2020 and making award in 2021 to obtain pharmacy services for the fifth generation of the TRICARE program.

View the file

Other files for this federal contract opportunity

Other files attached to DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5), newest first.
File Type Posted
DSADHA_SSVTemplate_20170101.pdf PDF
Responses to Industry on Revised Draft Section C 20200504.pdf PDF
TPharm5 - Overview of Changes to Draft Section C.DOCX DOCX document
DHA Responses to Industry on Draft RFP 20200318.pdf PDF
TPharm5 Draft RFP Info Session 20191211.pdf PDF
Attachment J-2 Acronym List.docx DOCX document
Attachment J-3 Website Links.docx DOCX document
Attachment L-5 Guaranty_Agreement.pdf PDF
Attachment L-9.3 Covered OTCs - Purchased Care.xlsx XLSX spreadsheet
Attachment L-19.1 PPI Tool Instructions.docx DOCX document
Data Pkg 3 TRICARE Retail Pharmacy Claim Volume.xlsx XLSX spreadsheet
TPharm5 Draft Section C 20191202.docx DOCX document
Data Pkg 6 - MOP Utilization.xlsx XLSX spreadsheet
Attachment L-13 VA_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Attachment L-1.2 Non-Disclosure Agreement.docx DOCX document
Data Pkg 21 Enrolled Beneficiary Population.xlsx XLSX spreadsheet
TPharm5 Draft Section H 20191121.docx DOCX document
Data Pkg 10 - Compound Utilizers.xlsx XLSX spreadsheet
TPharm5 Draft Section I 20191120.docx DOCX document
Data Pkg 11 - Retail Utilization Detail, Guarantee Categories.xlsx XLSX spreadsheet
TPharm5 Draft Section F 20191202.docx DOCX document
Data Pkg 19 Historical_TMDS_Volume_2017-2018.xlsx XLSX spreadsheet
Attachment L-9.4 Covered OTC List - MHS GENESIS.xlsx XLSX spreadsheet
Data Pkg 13 - MTF Claims Volumes by Site.xlsx XLSX spreadsheet
Attachment L-3 Specialty Reimbursement for Use in Determining Incentiv....docx DOCX document
Attachment L-9 Benefit Design Document_TPharm5.xlsx XLSX spreadsheet
Attachment L-2 Retail Network Reimbursement Table.docx DOCX document
TPharm5 Draft RFP READ FIRST 20191202.docx DOCX document
Tpharm5 Draft Section G 20191202.docx DOCX document
Attachment L-8 MMC Sample File.xlsx XLSX spreadsheet
Attachment L-9.8 PA_ST_QL List.XLSX XLSX spreadsheet
Attachment L-4 Negotiated Specialty Retail Replenished Dispensing Fees.docx DOCX document
Attachment L-9.9 Fluoride Products List.xlsx XLSX spreadsheet
Attachment L-12 IHS_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Data Pkg 15 IHS_Pharmacy_Claims_Volume_2017_&_2018.xlsx XLSX spreadsheet
TPharm5 Draft Section E 20191120.docx DOCX document
TPharm5 Draft Section D 20191120.docx DOCX document
Attachment L-1.1 List of Data Packages.docx DOCX document
Attachment L-19 Past Performance Questionnaire Template Tab F 20191120.docx DOCX document
Data Pkg 7 Specialty Drug Utilization, Retail and Mail.xlsx XLSX spreadsheet
Data Pkg 14 Retail Claims with COB.xlsx XLSX spreadsheet
Attachment J-5 TPharm5 Award Fee Plan 20191122.docx DOCX document
Data Pkg 5 MOP Utilization by Drug.xlsx XLSX spreadsheet
Data Pkg 23 - Paid Claims and Rejects - MHS GENESIS.xlsx XLSX spreadsheet
Data Pkg 22 - Paid Claims and Rejects - Retail.xlsx XLSX spreadsheet
Data Pkg 24 - CHCBP Volume.xlsx XLSX spreadsheet
Attachment L-9.6 Self-Admin Injectables List.xlsx XLSX spreadsheet
Attachment L-9.7 Expanded Use of MTF and TMOP List.xlsx XLSX spreadsheet
Attachment L-18 CDRL Supplemental Bid Schedule.xlsx XLSX spreadsheet
Attachment L-1 Ordering Instructions for Data Files not on SAM.gov.docx DOCX document
Show all 50

DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) has more files on GovTribe.

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Exhibit L-7 Sample Teaming Partner/Subcontractor Consent Letter Past performance information concerning subcontractors and teaming partners cannot be disclosed to a private party without the subcontractor’s or teaming partner’s consent. Because a prime contractor is a private party, the Government needs each subcontractor’s (teaming partner’s) consent before disclosing subcontractor/teaming partner past and present performance information to the prime contractor during exchanges if necessary. In an effort to assist the Government’s Source Selection Evaluation Board (SSEB) in assessing an offeror’s past performance relevancy, the offeror shall include the following consent letter for each subcontractor and partner of the joint venture, and/or consortium identified in their proposal in the offeror’s Volume 3, Past Performance. Past Performance Consent Letters are exempt from the page count.

SAMPLE (Printed on Company Letterhead)

Company: Date:

Address:

Dear “Contracting Officer:”

We are participating as a (subcontractor/teaming partner) with (name of prime contractor or entity providing proposal) in response to the Defense Health Agency (DHA) TRICARE Overseas Program 2021 (TOP 21), Solicitation HT9402-19-R-0001.

The Government is placing increased emphasis on past performance in order to obtain best value in source selections. In order to facilitate the performance assessment process, we are signing this consent letter to allow you to discuss our past performance information with the prime contractor during the source selection process.

(Signature and title of individual who has the authority to sign for and legally bind the company)

Company Name:________________________

Address:______________________________ HT940220R0002 Page 1 of 1 Attachment L-7

File details come from the government source that posted it. Updated .